cancer drug glutathione Frontiers Human cancer-associated fibroblasts enhance glutathione

Note: HIF-1, Hypoxia-inducible factor-1

Ho IL, Li CY, Wang F, Zhao L, Liu J, Yen EY, Dyke CA, Shah R, Liu Z, Cetin AO, Chu Y, Citron F, Attanasio S, Corti D, Darbaniyan F, Del Poggetto E, Loponte S, Liu J, Soeung M, Chen Z, Jiang S, Jiang H, Inoue A, Gao S, Deem A, Feng N, Ying H, Kim M, Giuliani V, Genovese G, Zhang J, Futreal A, Maitra A, Heffernan T, Wang L , Do KA, Gargiulo G, Draetta G, Carugo A, Lin R, Viale A

Plus the first specs, including a battery life better than Metas

We have shown in the lab that targeting this protein leaves the cancer cells exposed and vulnerable to oxidative stress, blocking their ability to invade other tissues

Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: expression and prognostic value